Choosing the optimal therapeutic strategy for placental polyps using power Doppler color scoring: Transarterial embolization followed by hysteroscopic resection or expectant management?-Reference-Cited by-同舟云学术

Choosing the optimal therapeutic strategy for placental polyps using power Doppler color scoring: Transarterial embolization followed by hysteroscopic resection or expectant management?

Published:2016-08 Issue:4 Volume:55 Page:534-538
ISSN:1028-4559
Container-title:Taiwanese Journal of Obstetrics and Gynecology
language:en
Short-container-title:Taiwanese Journal of Obstetrics and Gynecology

Author:

Mori Masahiko,Iwase Akira,Osuka Satoko,Kondo Mika,Nakamura Tomoko,Nakahara Tatsuo,Goto Maki,Kikkawa Fumitaka

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference13 articles.

1. Management of retained products of conception with marked vascularity;Kitahara;J Obstet Gynaecol Res,2011

2. Placental polyp with prominent neovascularization;Takeda;Fertil Steril,2010

3. Modern management of hypervascular placental polypoid mass following spontaneous abortion: a case report and literature review;Marques;Am J Obstet Gynecol,2011

4. Computed tomographic angiography in diagnosis and management of placental polyp with neovascularization;Takeda;Arch Gynecol Obstet,2010

5. The use of power Doppler colour scoring to predict successful expectant management in women with an incomplete miscarriage;Casikar;Hum Reprod,2012

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A hypervascular placental polyp after complete abortion: a case report;BMC Women's Health;2023-10-10

2. Management of Hypervascular Retained Products of Conception With Massive Bleeding;Cureus;2023-09-25

3. Predictive factors for massive hemorrhage in women with retained products of conception: a prospective study;Scientific Reports;2022-07-13

4. Pólipo placentario hipervascular posparto;Revista Peruana de Ginecología y Obstetricia;2022-07-06

5. Placental polyp with arteriovenous malformation treated with a gonadotoropin-releasing hormone antagonist;BMJ Case Reports;2021-09